130 related articles for article (PubMed ID: 31271865)
1. Crystal structure of the CTLD7 domain of human M-type phospholipase A2 receptor.
Yu B; Hu Z; Kong D; Cheng C; He Y
J Struct Biol; 2019 Sep; 207(3):295-300. PubMed ID: 31271865
[TBL] [Abstract][Full Text] [Related]
2. Structural determinants of the dominant conformational epitopes of phospholipase A2 receptor in primary membranous nephropathy.
Tang H; Zhu R; Waldman M; Zhu Q
J Biol Chem; 2022 Mar; 298(3):101605. PubMed ID: 35065076
[TBL] [Abstract][Full Text] [Related]
3. An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor.
Behnert A; Fritzler MJ; Teng B; Zhang M; Bollig F; Haller H; Skoberne A; Mahler M; Schiffer M
PLoS One; 2013; 8(4):e61669. PubMed ID: 23637879
[TBL] [Abstract][Full Text] [Related]
4. Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.
Kao L; Lam V; Waldman M; Glassock RJ; Zhu Q
J Am Soc Nephrol; 2015 Feb; 26(2):291-301. PubMed ID: 25205735
[TBL] [Abstract][Full Text] [Related]
5. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy.
Fresquet M; Jowitt TA; Gummadova J; Collins R; O'Cualain R; McKenzie EA; Lennon R; Brenchley PE
J Am Soc Nephrol; 2015 Feb; 26(2):302-13. PubMed ID: 25288605
[TBL] [Abstract][Full Text] [Related]
6. Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.
Seitz-Polski B; Dolla G; Payré C; Girard CA; Polidori J; Zorzi K; Birgy-Barelli E; Jullien P; Courivaud C; Krummel T; Benzaken S; Bernard G; Burtey S; Mariat C; Esnault VL; Lambeau G
J Am Soc Nephrol; 2016 May; 27(5):1517-33. PubMed ID: 26567246
[TBL] [Abstract][Full Text] [Related]
7. Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Wang C; Lu H; Yang C; Luo Y
Chin Med J (Engl); 2014; 127(10):1960-3. PubMed ID: 24824263
[TBL] [Abstract][Full Text] [Related]
8. Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
Liu X; Xue J; Li T; Wu Q; Sheng H; Yang X; Lin B; Zhou X; Qin Y; Huang Z; Zhou L; Wang L; Hu Z; Huang B
PLoS One; 2024; 19(2):e0298269. PubMed ID: 38386672
[TBL] [Abstract][Full Text] [Related]
9. Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch.
Fresquet M; Lockhart-Cairns MP; Rhoden SJ; Jowitt TA; Briggs DC; Baldock C; Brenchley PE; Lennon R
Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2202209119. PubMed ID: 35858348
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696
[TBL] [Abstract][Full Text] [Related]
11. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
[TBL] [Abstract][Full Text] [Related]
13. Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
Ruggenenti P; Reinhard L; Ruggiero B; Perna A; Perico L; Peracchi T; Fidone D; Gennarini A; Benigni A; Cortinovis M; Hoxha E; Remuzzi G
Am J Kidney Dis; 2024 May; 83(5):588-600.e1. PubMed ID: 38151224
[TBL] [Abstract][Full Text] [Related]
14. Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy.
Zhang XD; Lin CX; Cui Z; Gu QH; Yan BJ; Liu L; Song WC; Shi Y; Debiec H; Ronco P; Zhao MH
Kidney Int; 2023 Mar; 103(3):580-592. PubMed ID: 36549363
[TBL] [Abstract][Full Text] [Related]
15. Clinical Relevance of Domain-Specific Phospholipase A
Reinhard L; Zahner G; Menzel S; Koch-Nolte F; Stahl RAK; Hoxha E
J Am Soc Nephrol; 2020 Jan; 31(1):197-207. PubMed ID: 31843985
[TBL] [Abstract][Full Text] [Related]
16. Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain.
Fresquet M; Rhoden SJ; Jowitt TA; McKenzie EA; Roberts I; Lennon R; Brenchley PE
J Autoimmun; 2020 Jan; 106():102308. PubMed ID: 31395435
[TBL] [Abstract][Full Text] [Related]
17. Structure of Human M-type Phospholipase A2 Receptor Revealed by Cryo-Electron Microscopy.
Dong Y; Cao L; Tang H; Shi X; He Y
J Mol Biol; 2017 Dec; 429(24):3825-3835. PubMed ID: 29079480
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
[TBL] [Abstract][Full Text] [Related]
19. Immunology of membranous nephropathy: from animal models to humans.
Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]